Valentino Cherubini, Italy
Azienda Ospedaliero-Universitaria Ospedali Riuniti Ancona Women's and Children's HealthPresenter of 1 Presentation
VIRTUAL CAMP EFFECTIVENESS TO START NEW TECHNOLOGIES IN FAMILIES WITH CHILDREN LIVING WITH TYPE 1 DIABETES
- Valentino Cherubini, Italy
- Rosaria Gesuita, Italy
- Riccardo Bonfanti, Italy
- Sara Giorda, Italy
- Lorenzo Lenzi, Italy
- Claudio Maffeis, Italy
- Marco Marigliano, Italy
- Monica Marino, Italy
- Ivana Rabbone, Italy
- Riccardo Schiaffini, Italy
- Sonia Toni, Italy
- Andrea Rigamonti, Italy
- Barbara Piccini, Italy
- Andrea E. Scaramuzza, Italy
- Virtual Camp Study Group, Italy
Abstract
Background and Aims
To analyze the impact of an educational Virtual Camp (eVC) in children with T1D and their parents on glucose control.
Methods
Nineteen Italian centers for pediatric diabetes participated. The eVC was held from 6 to 8 November 2020; it involved parents and their children aged 6-17 years who previously updated their pump software from Tandem Basal-IQ to Control-IQ technology. Several interactive sessions involving pediatric diabetologists, psychologists, dieticians and physical education teachers have been performed during the eVC. Eight weeks before the update to Control-IQ and eight weeks after eVC, CGM metrics were downloaded and summarized using median and interquartile range (IQR) and compared by Wilcoxon sign-rank test. Median differences and 95%CI were estimated.
Results
43 children, 53.5% females, median age 15y and diabetes duration 10y, were included. After the eVC, the percentage of time in range and time above range significantly improved (Table 1); %CV and %GMI significantly decreased; IQR values showed a lower interindividual variability when using the updated algorithm. In addition, a significant reduction of daily percentage of bolus insulin was reported.
Conclusions
A significant huge improvement of glucose metrics was observed in children with T1D using Control-IQ technology after a 3-day eVC. More than 75% of children maintained a percentage of TIR over 70% during an 8-week period after eVC, suggesting that, despite forced interruption of clinical visits due to Covid-19 pandemic, the eVC is a useful tool to start new technological devices.